• Job Description

  Req#: 295108

  About the Department

  Novo Nordisk’s Market Access and Public Affairs team engages diverse stakeholders across political and healthcare landscapes to forge solutions that drive patient access to innovative products. We strive to deliver the best possible outcomes for patients with diabetes, obesity, growth hormone deficiencies and rare bleeding disorders through mutual wins for both Novo Nordisk and our Market Access customers. Our passion for helping people live better lives and our award-winning product pipeline can only be as effective as our ability to provide life-changing information to healthcare providers, key stakeholders and policymakers. Our Market Access and Public Affairs professionals ensure that the latest therapies and products reach the people who need them most, by creating an environment where innovation and chronic disease management drive optimal health outcomes. Are you ready to realize your potential?

  The Program

  At Novo Nordisk, interns will have the opportunity to work closely with experienced industry professionals and gain valuable, hands-on, full-time work experience. For ten weeks, interns will be immersed in the environment of a global pharmaceutical company and contribute to the line of business by providing sustainable and meaningful project work. Our internship program also includes instructor led trainings, a leadership engagement series, and a guided mentorship program to offer professional and personal development.

  In addition to individual department responsibilities, interns will also participate in the program’s capstone event, the Innovation in Action Case Competition. Assigned to cross-functional teams, interns will work closely to develop an innovative and comprehensive solution to a business problem currently facing Novo Nordisk. At the conclusion of the program, teams will present their findings to a board of top Novo Nordisk officials representing the various lines of business.

  Program Start: June 3rd, 2024.

  Program End: August 9th, 2024.

  Scope of Position

  Novo Nordisk is on an ambitious journey to improve the lives of people living with MASH (formerly NASH, Metabolic Dysfunction-Associated Steatohepatitis). MASH is a highly prevalent disease affecting 3-5% of the United States population. Of those affected it is estimated that as few as 0.15% have received a diagnosis. In order for Novo Nordisk to support those living with MASH with treatment, it is vital that they are identified and provided with support as soon as possible.

  As a member of the Liver Health Market Access Team, the intern will work independently and under the guidance of senior staff members to design and execute research studies, analyze data, and develop recommendations based on their findings. The intern will be expected to stay up to date on the latest research and trends in the field of non-invasive testing for MASH and work collaboratively with other team members to achieve project goals.

  Expected Tasks:

  • Conduct literature reviews and synthesize relevant research on non-invasive testing for MASH.

  • Design and execute research studies to further understand the use of non-invasive testing for MASH.

  • Develop recommendations based on research findings and effectively communicate findings to the team and stakeholders.

  • Participate in team meetings and contribute to the development of project strategies and goals.

  • Assist with other tasks and ad-hoc projects as necessary to support the team's objectives.

  Physical Requirements

  • 0% overnight travel required.

  Qualifications

  • Must be a current student enrolled or recently graduated (graduation date no earlier than April 2024) at/from an accredited college or university pursuing at least a bachelor’s degree.

  • A completed or in progress undergraduate, graduate, or doctoral degree in Biomedical Science, Public Health, Healthcare Management or a related discipline preferred.

  • Experience with systematic literature reviews and associated software tools preferred.

  • Strong academic record with a preferred cumulative GPA of 3.0 or higher.

  • Conscientious self-starter with good organizational skills, project management skills and attention to detail.

  • Ability to balance multiple projects and priorities, must be able to multi-task.

  • Strong interpersonal communication and ability to collaborate with teams; must effectively operate independently, across functional lines, and with internal customers.

  • Demonstrated personal initiative, self-motivation, flexibility, adaptability and willingness to learn.

  • Proficient in Microsoft Office Tools including Word, Excel, PowerPoint, etc.

  At this time, Novo Nordisk is not currently hiring individuals for this position who now or in the future would require sponsorship for employment visa status.

  We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

  At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.

  Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.

  If you are interested in applying to Novo Nordisk and need special assistance or an accommodation to apply, please call us at 1-855-411-5290. This contact is for accommodation requests only and cannot be used to inquire about the status of applications.

• About the company

  Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in eight countries, and affiliates or offices in 5 countries.

Notice